← Eichor
Study identifier: NCT07620223 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Prophylactic Antibiotics in Preventing Surgical Site Infection After Hepatobiliary Surgery in High-Resistant Settings

Condition: Hepatobiliary Surgery · Prophylactic Antibiotics  ·  Sponsor: The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School

PhaseNA
Planned participants378
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

To analyse the efficacy of different preoperative prophylactic antimicrobial regimens for perioperative infection prevention in patients undergoing hepatobiliary surgery in a high antimicrobial resistance setting.

This description comes directly from the study's public registry record.

Talk to the study team

Dayu Chen, Pharmacist in Charge, PharmD  ·  +86-025-83106666-60924  ·  cdy_pharmacy@njglyy.com

Always discuss trial participation with your own doctor first.

Locations (1)

Nanjing Drum Tower HospitalNanjing, Jiangsu, ChinaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07620223